Elmer Video

Clininal Study Reporting Guidelines


Randomized trials (CONSORT)
Observational studies (STROBE)
Systematic reviews (PRISMA)
Case reports (CARE)
Qualitative research (SRQR
Diagnostic / prognostic studies (STARD)
Quality improvement studies (SQUIRE)
Economic evaluations (CHEERS)  
Animal pre-clinical studies (ARRIVE)
Study protocols (SPIRIT)
Clinical practice guidelines (AGREE)


Publishing Policy

Elmer Press Publishing Policies, and Guidelines to follow, click for details......


Our journals are open access, which means all the contents of the journals are accessible freely to all viewers from every part of the world as long as they have internet accessibility, More...

Contact Us


Elmer Press Inc.
9225 Leslie Street, Suite 201
Richmond Hill
Ontario, L4B 3H6
Tel:  647-671-2629 (alternative email)

Journals in Web of Science-ESCI

Journals Permanent Archiving

All journals published by Elmer Press are archived in Portico, which provides permanent digital archiving for scholarly journals.

Follow Us

Invite Submissions


Publishing Highlights

• April 14, 2024

Spontaneous Adrenal Hemorrhage in Pregnancy
By Priyanka Desai et al. Journal of Clinical Gynecology and Obstetrics, Volume 13, Number 1, March 2024.

Spontaneous adrenal hemorrhage (SAH) is a serious medical condition that occurs due to acute damage to the adrenal gland or chronic atrophy of the adrenal gland. Although pregnancy is a known risk factor for adrenal hemorrhage, its etiology and incidence are unknown, causing it to be a rare and poorly understood disorder in obstetric patients.  Read More....


• April 7, 2024

Increased Prevalence of Advanced Metabolic Dysfunction-Associated Steatotic Liver Disease Fibrosis in Type 2 Diabetics Despite Low-Risk Fibrosis-4 Index Scores
By Jordan S. Woodard et al. Journal of Endocrinology and Metabolism, Volume 14, Number 1, February 2024.

The American Gastroenterology Association (AGA) guidelines for metabolic dysfunction-associated steatotic liver disease (MASLD) recommend screening for fibrosis in high-risk subjects with either type 2 diabetes, two or more metabolic risk factors, or steatosis on imaging. The aim of our study was to identify the prevalence of significant to advanced fibrosis in subjects with a low-risk FIB-4 value with FibroScan’s LSM in type 2 diabetes.  Read More....


• March 31, 2024

The Combination of Afatinib With Dasatinib or Miransertib Results in Synergistic Growth Inhibition of Stomach Cancer Cells
By Tina Al-Janaby et al. World Journal of Oncology, Volume 15, Number 2, April 2024.

Of various human epidermal growth factor receptor (HER) inhibitors, only the anti-HER2 monoclonal antibody (mAb) Herceptin/trastuzumab and the antibody-drug conjugate trastuzumab deruxtecan (T-Dxd) has been approved for the treatment of patients with stomach cancer. Read More....


• March 10, 2024

Characteristics and Outcomes of Atrial Fibrillation in Chronic Heart Failure Patients
By Alex Rivera-Toquica et al. Cardiology Research, Volume 15, Number 1, February 2024.

Heart failure (HF) and atrial fibrillation (AF) represent conditions that commonly coexist. The impact of AF in HF has yet to be well studied in Latin America. This study aimed to characterize the sociodemographic and clinical features, along with patients’ outcomes with AF and HF from the Colombian Heart Failure Registry (RECOLFACA).  Read More....


• March 9, 2024

Associations Between Type 2 Diabetes Subtypes and Complications: Analysis of the Malaysia National Diabetes Registry
By Rasa Kazlauskaite et al. Journal of Endocrinology and Metabolism, Volume 14, Number 1, February 2023.

The aim of the study was to investigate type 2 diabetes (DM2) subtypes and associations with complications in a multiethnic Asian population. DM2 subtypes associate differently with complications in Malaysia, similar to patterns found in European cohorts. DM2 subtypes complications, particularly for advanced CKD, are affected by registry-related selection bias and deserve further longitudinal investigation.  Read More....